BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8298448)

  • 1. Characterization of tumour infiltrating lymphocytes in human breast cancer.
    Chin Y; Janssens J; Bleus J; Vandepitte J; Vandenbrande J; Raus J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():27-31. PubMed ID: 8298448
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.
    Hillenbrand EE; Neville AM; Coventry BJ
    Br J Cancer; 1999 Feb; 79(5-6):940-4. PubMed ID: 10070894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine in human breast cancer.
    Reynolds JL; Akhter JA; Magarey CJ; Schwartz P; Adams WJ; Morris DL
    Br J Surg; 1998 Apr; 85(4):538-41. PubMed ID: 9607543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: "Thorough intraoperative analysis of breast sentinel lymph node biopsies: Histologic and immunohistochemical findings".
    Griswold RD
    Surgery; 2004 Nov; 136(5):1101-2. PubMed ID: 15523411
    [No Abstract]   [Full Text] [Related]  

  • 5. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    Ziai J; Gilbert HN; Foreman O; Eastham-Anderson J; Chu F; Huseni M; Kim JM
    PLoS One; 2018; 13(1):e0190158. PubMed ID: 29320521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tumor-infiltrating antigen presenting cells by high intensity focused ultrasound ablation of human breast cancer.
    Xu ZL; Zhu XQ; Lu P; Zhou Q; Zhang J; Wu F
    Ultrasound Med Biol; 2009 Jan; 35(1):50-7. PubMed ID: 18950932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
    Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
    Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.
    Hornychova H; Melichar B; Tomsova M; Mergancova J; Urminska H; Ryska A
    Cancer Invest; 2008 Dec; 26(10):1024-31. PubMed ID: 19093260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
    Toso JF; Oei C; Oshidari F; Tartaglia J; Paoletti E; Lyerly HK; Talib S; Weinhold KJ
    Cancer Res; 1996 Jan; 56(1):16-20. PubMed ID: 8548758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells: at the clinical crossroads.
    Mulé JJ
    J Clin Invest; 2000 Mar; 105(6):707-8. PubMed ID: 10727437
    [No Abstract]   [Full Text] [Related]  

  • 12. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
    Suzuki A; Masuda A; Nagata H; Kameoka S; Kikawada Y; Yamakawa M; Kasajima T
    J Pathol; 2002 Jan; 196(1):37-43. PubMed ID: 11748640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro quantification of the cytotoxic T lymphocyte response against human telomerase reverse transcriptase in breast cancer.
    Amarnath SM; Dyer CE; Ramesh A; Iwuagwu O; Drew PJ; Greenman J
    Int J Oncol; 2004 Jul; 25(1):211-7. PubMed ID: 15202008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
    Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
    J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
    Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.
    Höhn H; Pilch H; Günzel S; Neukirch C; Hilmes C; Kaufmann A; Seliger B; Maeurer MJ
    J Immunol; 1999 Nov; 163(10):5715-22. PubMed ID: 10553103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cellular immunologic status of the laryngeal cancer patients].
    Huang Z; Han D; Bian Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(2):107-9. PubMed ID: 9387505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
    J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.